Quantum-Si’s (QSI) “Buy” Rating Reaffirmed at HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued on Tuesday, MarketBeat Ratings reports. They currently have a $4.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 314.51% from the stock’s current price.

Several other research analysts also recently commented on the stock. Alliance Global Partners reaffirmed a “buy” rating on shares of Quantum-Si in a research note on Friday, August 14th. Wall Street Zen raised shares of Quantum-Si from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Finally, Weiss Ratings raised shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $2.50.

Quantum-Si Price Performance

Shares of Quantum-Si stock traded up $0.17 during trading on Tuesday, hitting $0.97. The stock had a trading volume of 6,937,626 shares, compared to its average volume of 4,314,413. The firm’s fifty day simple moving average is $0.77 and its 200-day simple moving average is $0.87. The stock has a market cap of $211.22 million, a PE ratio of -2.09 and a beta of 3.25. Quantum-Si has a 12 month low of $0.69 and a 12 month high of $3.10.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11). The firm had revenue of $0.34 million during the quarter, compared to analyst estimates of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. Analysts expect that Quantum-Si will post -0.47 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in QSI. IPG Investment Advisors LLC purchased a new position in Quantum-Si during the 2nd quarter valued at about $27,000. WINTON GROUP Ltd purchased a new position in Quantum-Si during the 2nd quarter valued at about $67,000. Corient Private Wealth LP purchased a new position in Quantum-Si during the 2nd quarter valued at about $34,000. Green Alpha Advisors LLC purchased a new position in Quantum-Si during the 2nd quarter valued at about $41,000. Finally, Renaissance Technologies LLC purchased a new position in Quantum-Si during the 1st quarter valued at about $91,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.